HLA class II alleles in Chinese patients with hepatocellular carcinoma

Liver

Volumn 21, Issue 2, 2001, Pages 143-148

  Donaldson, P T ^a   Ho, S ^b   Williams, R ^c   Johnson, P J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Genetic associations, susceptibility; Hepatitis B virus (HBV); Hepatocellular carcinoma (HCC); Hong Kong Chinese, susceptibility; Human leucocyte antigens (HLA)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HEPATITIS B; HLA SYSTEM; HONG KONG; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PHENOTYPE; RISK FACTOR; SEROLOGY;

ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CHINA; DNA, NEOPLASM; FEMALE; GENES, MHC CLASS II; HISTOCOMPATIBILITY TESTING; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HONG KONG; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION;

EID: 0035040651     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.021002143.x     Document Type: Article

References (63)

1. Hepatocellular carcinoma and hepatitis B virus a prospective study of 22,707 men in Taiwan
2. Hepatitis B virus is the etiological agent in hepatocellular carcinoma - Epidemiological consideration
3. Hepatitis B virus: The major etiological factor in hepatocellular carcinoma
4. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma
5. Hepatitis B virus infection and primary hepatocellular carcinoma
6. From hepatitis to hepatoma: Lessons from type B viral hepatitis
7. Hepatitis virus related hepatocarcinogenesis
8. Viruses and hepatocellular carcinoma
9. Genetic and familial aspects of liver cirrhosis and hepatocellular carcinoma
10. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients
11. HLA antigens and hepatocellular carcinoma
12. HLA antigens in Chinese patients with hepatocellular carcinoma
13. Histocompatibility profile of hepatoma in Taiwan
14. The distribution of HLA A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in Taiwan
15. HLA A, B, C and DR antigens in chronic hepatitis B viral infection
16. Molecular genetics of autoimmune liver disease
17. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
18. HLA, DQA, DQB, and DRB genotyping by oligonucleotide analysis: Distribution of alleles and haplotypes in British Caucasoids
19. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis
20. Allelic basis for HLA encoded susceptibility to type 1 autoimmune hepatitis
21. HLA DR typing by PCR amplification with sequence specific primers (PCR SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation
22. Estimation of means of dependent variables
23. Multiple comparisons among means
24. On estimating the relation between blood group and disease
25. Restriction fragment length polymorphism of HLA DQ and DR allogenotypes in normal southern Chinese
26. HLA DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high risk DQB1*0602 allele
27. Distribution and co occurrence of MHC class I, II and III markers in southern Chinese: Implications for autoimmune disease
28. Distribution of HLA class II alleles among Norwegian Caucasians
29. Frequency and associations of HLA class II Taq1 allogenotypes in the Northern Ireland population
30. No adjustments are needed for multiple comparisons
31. What's wrong with Bonferroni's adjustments?
32. Multiple comparisons and related sissues in the interpretation of epidemiologic data
33. Host genetic factors influence disease progression in chronic hepatitis C
34. Freely associating
35. Interpretation of results from genetic studies of multifactorial disease
36. Association studies of genetic polymorphisms in complex disease
37. Malignancy
38. Nasopharyngeal carcinoma in Alaskan Eskimo Indians, and Aluets: A review of cases and study of Epstein-Barr virus, HLA and environmental risk factors
39. High risk of squamous cell carcinoma of the cervix for women with HLA DQw3
40. HLA antigens and cervical carcinoma
41. Comparison of human leucocyte antigen DR DQ disease associations found with cervical dysplasia and invasive carcinoma
42. Association between HLA DQB1*03 and cervical intra epithelial neoplasia
43. Association of human leucocyte antigen B1*03 with cervical cancer in Japanese women aged 35 years and younger
44. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region
45. An international study of the association between HLA DP and Hodgkin's disease
46. A cohort study of the risk of cervical intra epithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
47. HLA and hepatitis B infection
48. HLA antigens in patients with various courses after hepatitis B virus infection
49. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
50. Association between HLA class II genotype and spontaneous clearance of HCV infection
51. HLA and susceptibility to hepatitis C virus - Commentary
52. Chronic viral hepatitis and the human genome
53. Non responsiveness to hepatitis B vaccine in health care workers
54. Lack of a response to recombinant hepatitis B vaccine in non responders to plasma vaccine
55. Contibution of human leucocyte antigens to the antibody response to hepatitis B vaccination
56. Immunological studies before and during interferon therapy in chronic HBV infection: Identification of factors predicting response
57. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
58. Selective G to M mutations of p53 gene in hepatocellular carcinoma from southern Africa
59. Mutational hotspot in the p53 gene in human hepatocellular carcinoma
60. Tumour suppressor genes, growth factor genes, and oncogenes in hepatitis B virus associated hepatocellular carcinoma
61. Hepatitis B X gene expression in hepatocellular carcinoma
62. HBx gene of hepatitis B induces liver cancer in transgenic mice